Not Rated
|
Fund Size
(0.53% of Investment in Category)
|
Expense Ratio
(0.88% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 07-Nov-25 | 10084.90 | 0.85% | - | 1.06% | 134/230 |
| 1 Month | 14-Oct-25 | 10037.80 | 0.38% | - | 2.14% | 203/226 |
| 3 Month | 14-Aug-25 | 10019.10 | 0.19% | - | 4.73% | 213/224 |
| 6 Month | 14-May-25 | 10678.90 | 6.79% | - | 8.05% | 126/214 |
| YTD | 01-Jan-25 | 9904.10 | -0.96% | - | 5.51% | 157/201 |
| 1 Year | 14-Nov-24 | 10666.00 | 6.66% | 6.66% | 8.71% | 112/187 |
| 2 Year | 13-Nov-23 | 15161.90 | 51.62% | 23.06% | 20.48% | 39/141 |
| 3 Year | 14-Nov-22 | 18410.60 | 84.11% | 22.54% | 20.32% | 39/117 |
| 5 Year | 13-Nov-20 | 24150.50 | 141.50% | 19.26% | 22.29% | 62/93 |
| Since Inception | 02-Jul-18 | 43495.00 | 334.95% | 22.06% | 14.34% | 29/199 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 14-Nov-24 | 12000 | 12571.96 | 4.77 % | 8.92 % |
| 2 Year | 13-Nov-23 | 24000 | 27519.42 | 14.66 % | 13.73 % |
| 3 Year | 14-Nov-22 | 36000 | 49189.53 | 36.64 % | 21.32 % |
| 5 Year | 13-Nov-20 | 60000 | 95917.28 | 59.86 % | 18.81 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 3388.9 | 12.01% | 0.44% | 12.5% (Apr 2025) | 10.74% (Jul 2025) | 20.04 L | 0.00 |
| Divis Laboratories Ltd. | Pharmaceuticals | 2504.4 | 8.88% | 1.12% | 8.88% (Oct 2025) | 5.35% (Nov 2024) | 3.72 L | -5.00 k |
| Glenmark Pharmaceuticals Ltd. | Pharmaceuticals | 1808.1 | 6.41% | -0.56% | 7.24% (Jul 2025) | 5.22% (Apr 2025) | 9.56 L | -0.30 L |
| Apollo Hospitals Enterprises Ltd. | Hospital | 1751.6 | 6.21% | -0.02% | 6.37% (Jun 2025) | 4.82% (Dec 2024) | 2.28 L | -4.00 k |
| Cipla Ltd. | Pharmaceuticals | 1528.4 | 5.42% | -0.61% | 7.6% (Feb 2025) | 5.42% (Oct 2025) | 10.18 L | -0.90 L |
| Lupin Ltd. | Pharmaceuticals | 1431.7 | 5.07% | 0.03% | 6.37% (Apr 2025) | 4.94% (Jul 2025) | 7.29 L | 0.00 |
| Fortis Healthcare Ltd. | Hospital | 1220.6 | 4.33% | 0.14% | 4.33% (Oct 2025) | 2.12% (Jan 2025) | 11.93 L | 0.00 |
| Aurobindo Pharma Ltd. | Pharmaceuticals | 1153.1 | 4.09% | -0.24% | 7.62% (Dec 2024) | 4.09% (Oct 2025) | 10.12 L | -0.90 L |
| Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 1133.5 | 4.02% | -0.18% | 6.38% (Dec 2024) | 4.02% (Oct 2025) | 9.46 L | 0.00 |
| Krishna Institute of Medical Sciences Ltd. | Hospital | 1064 | 3.77% | 0.03% | 4.32% (Nov 2024) | 3.57% (Feb 2025) | 14.76 L | 0.00 |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 0.78% |
| MF Units | MF Units | 0.01% |
| Net Receivables | Net Receivables | -0.10% |
Ratios calculated on daily returns for last 3 years (Updated as on 31st October, 2025)
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity Fund - Direct Plan - Growth | NA | 421.51 | 4.21 | 14.03 | 46.24 | 44.70 | 37.87 |
| Aditya Birla Sun Life International Equity Fund - Direct Plan - Growth | NA | 273.51 | -0.58 | 2.66 | 16.83 | 29.79 | 15.87 |
| Franklin Asian Equity Fund - Direct - Growth | NA | 297.12 | 5.18 | 10.51 | 19.92 | 26.94 | 14.82 |
| Quant BFSI Fund - Direct Plan - Growth | NA | 680.73 | 4.78 | 9.14 | 20.47 | 26.41 | 0.00 |
| HDFC Transportation and Logistics Fund - Direct Plan - Growth | NA | 1733.63 | 0.21 | 10.07 | 21.28 | 24.40 | 0.00 |
| Nippon India Japan Equity Fund - Direct Plan - Growth | NA | 292.35 | 3.74 | 4.50 | 14.80 | 24.22 | 18.39 |
| ITI Banking and Financial Services Fund - Direct Plan - Growth | NA | 333.18 | 5.07 | 8.69 | 9.87 | 23.19 | 15.72 |
| HDFC Defence Fund - Direct Plan - Growth | NA | 7556.72 | 1.80 | 5.87 | 11.55 | 23.19 | 0.00 |
| SBI Banking & Financial Services Fund - Direct Plan - Growth | NA | 9273.44 | 4.25 | 6.87 | 12.25 | 22.89 | 21.04 |
| DSP Banking & Financial Services Fund - Direct Plan - Growth | NA | 1518.73 | 3.04 | 7.71 | 8.90 | 22.66 | 0.00 |
Out of 52 mutual fund schemes offered by this AMC, 3 is/are ranked 5 * , 4 is/are ranked 4 * , 4 is/are ranked 3 * , 4 is/are ranked 2 * , and 37 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Mirae Asset Large & Midcap Fund - Direct Plan - Growth | 3 | 42980.74 | 2.96 | 6.93 | 9.93 | 12.44 | 18.27 |
| Mirae Asset Large Cap Fund - Direct Plan - Growth | 3 | 41087.55 | 3.16 | 5.12 | 7.15 | 11.42 | 14.11 |
| Mirae Asset ELSS Tax Saver Fund - Direct Plan - Growth | 4 | 27069.09 | 2.96 | 6.18 | 9.11 | 13.16 | 18.37 |
| Mirae Asset Midcap Fund - Direct Plan - Growth | 3 | 18112.14 | 2.88 | 7.59 | 14.38 | 14.41 | 21.74 |
| Mirae Asset Liquid Fund - Direct Plan - Growth | 4 | 14283.52 | 0.49 | 1.46 | 3.04 | 6.74 | 7.09 |
| Mirae Asset Aggressive Hybrid Fund - Direct Plan - Growth | 3 | 9424.67 | 2.46 | 4.41 | 6.70 | 11.54 | 15.04 |
| Mirae Asset Focused Fund - Direct Plan - Growth | 2 | 7979.98 | 1.08 | 3.12 | 5.60 | 6.90 | 12.56 |
| Mirae Asset Great Consumer Fund - Direct Plan - Growth | NA | 4769.48 | 1.13 | 3.79 | 8.13 | 9.05 | 18.88 |
| Mirae Asset Multicap Fund - Direct Plan - Growth | NA | 4388.81 | 2.21 | 5.55 | 9.70 | 13.17 | 0.00 |
| Mirae Asset Money Market Fund - Direct Plan - Growth | 5 | 3514.10 | 0.51 | 1.52 | 3.40 | 7.75 | 7.56 |